Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/1/05 → 12/31/08 |
A Twelve-Month, Open Label, Multicenter Study to Evaluate the Safety of a 1.3 g Oral Dose of a New Modified-Release Tranexamic Acid Formulation Administered Three Times Daily as Needed for up to 5 Days During the
- Muse, Kenneth (PI)